Overview
Ophthalmomandibulomelic dysplasia (OMMD), also known as pillay syndrome, is an extremely rare congenital disorder characterized by a triad of abnormalities affecting the eyes, jaw, and limbs. The condition was first described in 1964 and only a very small number of cases have been reported in the medical literature. The key clinical features include corneal opacities or other eye abnormalities (such as corneal clouding and temporalization of the inner canthi), hypoplasia or fusion abnormalities of the mandible (underdevelopment of the jawbone, sometimes with temporomandibular joint fusion leading to limited mouth opening), and limb defects predominantly affecting the upper extremities. Limb anomalies may include absent or hypoplastic radius, radioulnar synostosis, and other forearm malformations. These skeletal abnormalities can significantly impact hand and arm function. Due to the extreme rarity of this condition, there is no specific treatment. Management is supportive and symptomatic, typically involving a multidisciplinary team including ophthalmologists, orthopedic surgeons, oral and maxillofacial surgeons, and geneticists. Surgical interventions may be considered to address corneal opacities, improve jaw mobility, or correct limb deformities. The underlying genetic cause has not been definitively established, and the inheritance pattern remains uncertain, though autosomal dominant transmission has been suggested in some reported families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Ophthalmomandibulomelic dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ophthalmomandibulomelic dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Ophthalmomandibulomelic dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ophthalmomandibulomelic dysplasia.
Community
No community posts yet. Be the first to share your experience with Ophthalmomandibulomelic dysplasia.
Start the conversation →Latest news about Ophthalmomandibulomelic dysplasia
No recent news articles for Ophthalmomandibulomelic dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ophthalmomandibulomelic dysplasia
What is Ophthalmomandibulomelic dysplasia?
Ophthalmomandibulomelic dysplasia (OMMD), also known as pillay syndrome, is an extremely rare congenital disorder characterized by a triad of abnormalities affecting the eyes, jaw, and limbs. The condition was first described in 1964 and only a very small number of cases have been reported in the medical literature. The key clinical features include corneal opacities or other eye abnormalities (such as corneal clouding and temporalization of the inner canthi), hypoplasia or fusion abnormalities of the mandible (underdevelopment of the jawbone, sometimes with temporomandibular joint fusion lea
How is Ophthalmomandibulomelic dysplasia inherited?
Ophthalmomandibulomelic dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ophthalmomandibulomelic dysplasia typically begin?
Typical onset of Ophthalmomandibulomelic dysplasia is neonatal. Age of onset can vary across affected individuals.